S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY

Go back to S&P 500 Q2 Stock Buybacks Fall 20.1% Sequentially, 13.7% YoY

Biogen (BIIB) Reports Initiation of New Global Clinical Trial, DEVOTE, Evaluating Higher Dose of SPINRAZA (nusinersen) & Additional Data

September 18, 2019 7:34 AM EDT

Biogen Inc. (NASDAQ: BIIB) today announced updates to the SPINRAZA (nusinersen) clinical development program including the initiation of a new global clinical trial, DEVOTE. The DEVOTE study will evaluate if a higher dose of SPINRAZA can provide even greater efficacy in the treatment of spinal muscular atrophy (SMA) across a broad patient population. In addition, new data further demonstrating the safety and... More

JPMorgan (JPM) Raises Quarterly Dividend 12.5% to $0.9; 3% Yield

September 17, 2019 4:20 PM EDT

JPMorgan (NYSE: JPM) declared a quarterly dividend of $0.9 per share, or $3.6 annualized. This is a 12.5% increase from the prior dividend of $0.8.

The dividend will... More

BMO Capital Reiterates Market Perform Rating on S&P Global (SPGI)

September 17, 2019 7:11 AM EDT

BMO Capital analyst Jeffrey Silber reiterated a Market Perform rating and $255.00 price target on S&P Global (NYSE: SPGI) after meeting with management. The meetings provided greater insight into the companys businesses.

In three of four segments, management believes SPGI offers must... More